Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/nrneurol.2012.222 | DOI Listing |
Publication Analysis
Top Keywords
epilepsy perampanel-new
4
perampanel-new promise
4
promise refractory
4
refractory epilepsy?
4
epilepsy
1
promise
1
refractory
1
epilepsy?
1
Similar Publications
Introduction: Perampanel--new mode of action and new option for patients with epilepsy.
Epilepsia
January 2014
Kork Epilepsy Center, Kehl-Kork, Germany.
With perampanel the first-in-class selective alpha-amino-3-hydroxy-5-methyl-4-isoxazolprepionic acid (AMPA) receptor antagonist has been finally approved for add-on treatment in patients with focal-onset seizures. This suggests additional therapeutic potential in hitherto difficult-to-treat epilepsies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!